The 2019 Executive Order on Advancing American Kidney Health set an ambitious goal for increasing home dialysis in the end-stage kidney disease (ESKD) patient population. This session examines best practices for early referral for home dialysis following a review of current renal replacement therapy status. Current strategies and future opportunities for increasing home dialysis options are explored.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 11/8/2022.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure: Speaker: Molly Cahill – Amgen, OPKO, Otsuka Speakers Bureau; Consultant, Otsuka
The speaker would like to apologize and make you aware that Roxadustat (FibroGen) was not approved in the US as expected due to COVID-19 delays and is now expected in early December. The speaker acknowledges no financial relationships with it or any of the new HIF anemia products she spoke about in this presentation.
There are no other disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome: Upon completion of this session the learner will state best practices that lead to early referrals to explore home dialysis options for patients with CKD.